血液透析患者血清心钠素、醛固酮RIA的水平分析
被引量：2
摘要
本文就尿毒症患者血液透析(HD)前后的心钠素(ANP)、醛固酮(Ald)进行观察分析，以探讨HD患者电解质与ANP及Ald之间的关系。
出处
《放射免疫学杂志》
CAS
1994年第2期107-108,共2页
Journal of Radioimmanology
参考文献1
-
1孔令山等编写,徐仁宝等.受体的基础与临床[M]上海科学技术出版社,1992.
同被引文献15
-
1申晓彧,边云飞,肖传实.氯沙坦钾与螺内酯合用对大鼠急性心肌梗死后心肌纤维化的影响[J].中国药物与临床,2006,6(3):179-181. 被引量：5
-
2Rostand SG,Rutsky EA. Cardiac disease in dialysis patients// Nissenson AR, Fine RN. Elinical Dialysis. 2nd ed. Norwalk: Appleton Andlange,1990:dO9-4d6.
-
3Pitt B,Zannad F,Remme WJ,et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med, 1999,341:709-717.
-
4Ikizler TA. Epidemiology of vascular disease in renal failure. Biood Purif, 2002,20(1) : 6-10.
-
5Foley RN,Parfrey PS,Samak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis, 1998,32(5 Suppl 3) : 112-119.
-
6Struthers AD,Mac Donald TM. Review of aldosterone and angiotensin Ⅱ-induced target organ damage and prevention.Cardiovasc Res, 2004,61 : 663-670.
-
7Taheri S, Mortazavi M, Shahidi S, et al. Pironolaetone in chronic hemodialysis patients improves cardiac function. Saudi J Kidney Dis Transpl, 2009,20(3) : 392-397.
-
8Han SM, Won YW, Yi JH, et al. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients. Nephrol Dial Transplant,2007,22:11502-11505.
-
9Rostand SG, Rutsky EA. Cardiac disease in dialysis patients//Nissenson AR, Fine RN. Elinical Dialysis. 2nd ed. Nowalk: Appleton Andlange, 1990.406-446.
-
10Pitt B, Zannad F, Remme WJ, et al. The effect of spironolaetone on morbidity and mortality in patients with severe heart failure. Nengl J Med, 1999,341:709-717.
-
1张勇,吴玉琼,陈维真,张子康,莫丛健.心钠素和甲状旁腺素对血液透析低血压的影响[J].标记免疫分析与临床,2002,9(2):73-75. 被引量：1
-
2肖建国,柳强.肝硬化患者联合检测心钠素及甲状腺激素的意义[J].医学理论与实践,2007,20(1):19-20. 被引量：1
-
3钱方方,李坚,李连喜,王东,陈军建.血清心钠素测定与诊断糖尿病心肌病可行性的研究[J].江苏大学学报（医学版）,2007,17(4):329-331. 被引量：1
-
4王艳,裴妙荣.组分配伍四逆汤对甲状腺功能减退并发高脂血症及心血管系统损害的影响[J].中西医结合心脑血管病杂志,2016,14(19):2236-2240. 被引量：8
